Key result
The Visceral Adiposity Index (VAI) was the most significant predictor of 10-year dyslipidemia incidence, with each unit increase associated with a 2.81-fold higher odds of developing the condition.
Why the study?
The study aimed to establish a 10-year dyslipidemia incidence model by investigating novel anthropometric indices using exploratory regression and data mining.
Do novel anthropometric indices like the Visceral Adiposity Index predict the 10-year incidence of dyslipidemia in healthy adults?
Cohort (n=1,776)
Do novel anthropometric indices like the Visceral Adiposity Index predict the 10-year incidence of dyslipidemia in healthy adults?
Odds Ratio: 2.81 (95% CI 2.07–3.81)
p-value: p=<0.001
The Visceral Adiposity Index (VAI) is a strong, independent predictor of the 10-year incidence of dyslipidemia, highlighting the critical role of visceral obesity in metabolic risk.
Should not yet change practice; leaves open external validation of this first VAI-centered 10-year model.
BACKGROUND: The aim was to establish a 10-year dyslipidemia incidence model, investigating novel anthropometric indices using exploratory regression and data mining. METHODS: This data mining study was conducted on people who were diagnosed with dyslipidemia in phase 2 (n = 1097) of the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) study, who were compared with healthy people in this phase (n = 679). The association of dyslipidemia with several novel anthropometric indices including Conicity Index (C-Index), Body Roundness Index (BRI), Visceral Adiposity Index (VAI), Lipid Accumulation Product (LAP), Abdominal Volume Index (AVI), Weight-Adjusted-Waist Index (WWI), A Body Shape Index (ABSI), Body Mass Index (BMI), Body Adiposity Index (BAI) and Body Surface Area (BSA) was evaluated. Logistic Regression (LR) and Decision Tree (DT) analysis were utilized to evaluate the association. The accuracy, sensitivity, and specificity of DT were assessed through the performance of a Receiver Operating Characteristic (ROC) curve using R software. RESULTS: A total of 1776 subjects without dyslipidemia during phase 1 were followed up in phase 2 and enrolled into the current study. The AUC of models A and B were 0.69 and 0.63 among subjects with dyslipidemia, respectively. VAI has been identified as a significant predictor of dyslipidemias (OR: 2.81, (95% CI: 2.07, 3.81)) in all models. Moreover, the DT showed that VAI followed by BMI and LAP were the most critical variables in predicting dyslipidemia incidence. CONCLUSIONS: Based on the results, model A had an acceptable performance for predicting 10 years of dyslipidemia incidence. Furthermore, the VAI, BMI, and LAP were the principal anthropometric factors for predicting dyslipidemia incidence by LR and DT models.
No takes yet. Share an insight, caveat, or question.
Takhttavous et al. (2024) conducted a cohort in Dyslipidemia (n=1,776). Visceral Adiposity Index (VAI) vs. Lower VAI was evaluated on 10-year incidence of dyslipidemia (OR 2.81, 95% CI 2.07, 3.81, p=<0.001). The Visceral Adiposity Index (VAI) was the most significant predictor of 10-year dyslipidemia incidence, with each unit increase associated with a 2.81-fold higher odds of developing the condition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: